Northern Trust Corp Eye Point Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 643,157 shares of EYPT stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

643,157

Previous 471,783 36.32%

Holding current value

$4.19 Million

Previous $3.77 Million 27.12%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.02 - $12.12 $1.2 Million - $2.08 Million	171,374 Added 36.32%	643,157 $4.79 Million
Q3 2024 Nov 13, 2024	BUY	$7.58 - $10.54 $1.15 Million - $1.6 Million	151,785 Added 47.43%	471,783 $3.77 Million
Q2 2024 Aug 14, 2024	SELL	$8.16 - $22.89 $18,172 - $50,976	-2,227 Reduced 0.69%	319,998 $2.78 Million
Q1 2024 May 14, 2024	BUY	$19.93 - $29.71 $1.65 Million - $2.45 Million	82,604 Added 34.47%	322,225 $6.66 Million
Q4 2023 Feb 13, 2024	BUY	$5.71 - $24.13 $159,343 - $673,371	27,906 Added 13.18%	239,621 $5.54 Million
Q3 2023 Nov 13, 2023	BUY	$7.99 - $15.36 $11,273 - $21,672	1,411 Added 0.67%	211,715 $1.69 Million
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $10,214 - $30,339	3,371 Added 1.63%	210,304 $1.83 Million
Q1 2023 May 15, 2023	BUY	$2.28 - $5.04 $7,134 - $15,770	3,129 Added 1.54%	206,933 $608,000
Q4 2022 Feb 13, 2023	SELL	$2.37 - $7.2 $13,298 - $40,399	-5,611 Reduced 2.68%	203,804 $713,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $32,252 - $51,530	-4,634 Reduced 2.16%	209,415 $1.66 Million
Q2 2022 Aug 12, 2022	BUY	$7.25 - $12.71 $37,729 - $66,142	5,204 Added 2.49%	214,049 $1.69 Million
Q1 2022 May 13, 2022	BUY	$8.67 - $14.11 $197,832 - $321,961	22,818 Added 12.27%	208,845 $2.54 Million
Q4 2021 Feb 08, 2022	SELL	$10.18 - $18.4 $69,234 - $125,138	-6,801 Reduced 3.53%	186,027 $2.28 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $924,067 - $1.44 Million	123,045 Added 176.33%	192,828 $2.01 Million
Q2 2021 Aug 13, 2021	BUY	$8.69 - $11.08 $210,836 - $268,822	24,262 Added 53.3%	69,783 $627,000
Q1 2021 May 12, 2021	BUY	$8.89 - $14.92 $271,998 - $456,492	30,596 Added 205.0%	45,521 $463,000
Q4 2020 Feb 11, 2021	BUY	$3.7 - $6.58 $55,222 - $98,206	14,925 New	14,925 $98,000

Others Institutions Holding EYPT

# of Institutions

156

Shares Held

72.4M

Call Options Held

187K

Put Options Held

225K

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $222M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Eye Point Pharmaceuticals, Inc. Transaction History